Johnson & Johnson’s latest earnings bested Wall Street estimates, as the company braces for one of its top-selling medicines ...

Johnson & Johnson reported better-than-expected quarterly revenue and profit on higher sales of cancer drugs and some medical devices. Yet the healthcare company faces headwinds in 2025—including a ...

Netflix stock soars after strong subscriber gains, and Oracle teams with OpenAI and SoftBank in a $500 billion AI ...

Johnson & Johnson , fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular , reported fourth-quarter ...

In today’s edition … Top Dem on Oversight Committee calls for Trump conflict of interest investigation ... DNC chair ...

Dow, S&P 500, and Nasdaq futures are rising in premarket trading Wednesday as the stock market braces for another day of Trump orders.

President Donald Trump wants to enact a sweeping, conservative agenda. House Speaker Mike Johnson could be key to getting ...

Here are some key corporate earnings, economic data releases, and other events to eye over the rest of this week: Today Earnings: Procter & Gamble, Johnson & Johnson, Abbott Laboratories and GE ...

The National Security Agency (NSA) has formally requested Nelsco A. Wolo, its Assistant Director for Operations, to return all agency property following his unauthorized participation in the funeral ...

Get ready for Wednesday's trading day that will be colored by AI enthusiasm and big-tech earnings expectations.

The Chicago Bears announced Tuesday that the team had reached an agreement with former Detroit Lions offensive coordinator to ...

Johnson & Johnson has secured FDA approval for expanded use of its Spravato nasal spray, now cleared as a standalone ...